D J Fitzgerald|G Mayo|F Catella|S S Entman|G A FitzGerald - JoVE Visualize

Showing results (231-240 of 524) with videos related to

Pageof 53

Sort By:

The Journal of Clinical Investigation|May 1, 1997

Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticlesO P Barry, D Pratico, J A Lawson, et al.

Annals of Medicine|February 24, 2001

Cyclo-oxygenase products and atherothrombosisG A FitzGerald, S Austin, K Egan, et al.

American Journal of Respiratory and Critical Care Medicine|April 1, 1994

Effect of oral prednisone on airway inflammatory mediators in atopic asthmaR Dworski, G A Fitzgerald, J A Oates, et al.

The New England Journal of Medicine|April 26, 1984

Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activationG A FitzGerald, B Smith, A K Pedersen, et al.

JASA Express Letters|December 20, 2021

Interaural-time-difference thresholds for broad band-limited pulses are affected by relative bandwidth not temporal envelope sharpnessPaul G Mayo, Philip C Saunders, Matthew J Goupell

Infection and Immunity|February 1, 1996

Furin regulates both the activation of Pseudomonas exotoxin A and the Quantity of the toxin receptor expressed on target cellsM Gu, V M Gordon, D J Fitzgerald, et al.

Clinical Science (London, England : 1979)|December 1, 1981

Accuracy of the London School of Hygiene and Remler M2000 sphygmomanometersD J Fitzgerald, W G O'Callaghan, K O'Malley, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 1, 1983

Enhancement of toxicity of antitransferrin receptor antibody-Pseudomonas exotoxin conjugates by adenovirusD J FitzGerald, I S Trowbridge, I Pastan, et al.

Cancer Research|January 1, 1991

Cytotoxic activity of a recombinant fusion protein between insulin-like growth factor I and Pseudomonas exotoxinT I Prior, L J Helman, D J FitzGerald, et al.

Cancer Research|June 1, 1991

Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma, PLC/PRF/5 in miceC B Siegall, R J Kreitman, D J FitzGerald, et al.

Pageof 53

Showing results (231-240 of 524) with videos related to

Sort By:

Pageof 53

The Journal of Clinical Investigation|May 1, 1997

Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticlesO P Barry, D Pratico, J A Lawson, et al.

Annals of Medicine|February 24, 2001

Cyclo-oxygenase products and atherothrombosisG A FitzGerald, S Austin, K Egan, et al.

American Journal of Respiratory and Critical Care Medicine|April 1, 1994

Effect of oral prednisone on airway inflammatory mediators in atopic asthmaR Dworski, G A Fitzgerald, J A Oates, et al.

The New England Journal of Medicine|April 26, 1984

Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activationG A FitzGerald, B Smith, A K Pedersen, et al.

JASA Express Letters|December 20, 2021

Interaural-time-difference thresholds for broad band-limited pulses are affected by relative bandwidth not temporal envelope sharpnessPaul G Mayo, Philip C Saunders, Matthew J Goupell

Infection and Immunity|February 1, 1996

Furin regulates both the activation of Pseudomonas exotoxin A and the Quantity of the toxin receptor expressed on target cellsM Gu, V M Gordon, D J Fitzgerald, et al.

Clinical Science (London, England : 1979)|December 1, 1981

Accuracy of the London School of Hygiene and Remler M2000 sphygmomanometersD J Fitzgerald, W G O'Callaghan, K O'Malley, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 1, 1983

Enhancement of toxicity of antitransferrin receptor antibody-Pseudomonas exotoxin conjugates by adenovirusD J FitzGerald, I S Trowbridge, I Pastan, et al.

Cancer Research|January 1, 1991

Cytotoxic activity of a recombinant fusion protein between insulin-like growth factor I and Pseudomonas exotoxinT I Prior, L J Helman, D J FitzGerald, et al.

Cancer Research|June 1, 1991

Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma, PLC/PRF/5 in miceC B Siegall, R J Kreitman, D J FitzGerald, et al.

Pageof 53